Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Aplaviroc (INN, codenamed AK602 and GSK-873140) is a CCR5 entry inhibitor that belongs to a class of 2,5-diketopiperazines developed for the treatment of HIV infection. It was developed by GlaxoSmithKline.
The analysis highlights Overview, Related Topics and Entities as prominent areas in the source structure around Aplaviroc.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Aplaviroc shows recurring relationship patterns in the source. For example, Aplaviroc → 461443-59-4 Y, HCl: 461023-63-2 Y Another extracted example is Aplaviroc → 98B425P30V, HCl: 04D148Z3VR Y. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
developed discontinued development ccr5 inn hiv glaxosmithkline codenamed ak602 gsk-873140 entry inhibitor belongs class 5-diketopiperazines treatment infection october 2005 studies
TTTA extracted 17 structured relationships around Aplaviroc. Examples in this analysis include Aplaviroc → 3D model (JSmol) → Interactive image and Aplaviroc → ATC code → none. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Aplaviroc | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Aplaviroc | ATC code | none | 1.00 | infobox |
| Aplaviroc | CAS Number | 461443-59-4 Y | 1.00 | infobox |
| Aplaviroc | CAS Number | HCl: 461023-63-2 Y | 1.00 | infobox |
| Aplaviroc | ChEMBL | ChEMBL1255794 | 1.00 | infobox |
| Aplaviroc | ChemSpider | 2272720 Y | 1.00 | infobox |
| Aplaviroc | CompTox Dashboard (EPA) | DTXSID6047317 | 1.00 | infobox |
| Aplaviroc | DrugBank | DB06497 Y | 1.00 | infobox |
| Aplaviroc | Formula | C33H43N3O6 | 1.00 | infobox |
| Aplaviroc | IUPHAR/BPS | 805 | 1.00 | infobox |
| Aplaviroc | KEGG | D06557 Y | 1.00 | infobox |
| Aplaviroc | Legal status | Development terminated | 1.00 | infobox |
| Aplaviroc | Molar mass | 577.722 g·mol−1 | 1.00 | infobox |
| Aplaviroc | PubChem CID | 3001322 | 1.00 | infobox |
| Aplaviroc | Routes of administration | Oral | 1.00 | infobox |
| Aplaviroc | UNII | 98B425P30V | 1.00 | infobox |
| Aplaviroc | UNII | HCl: 04D148Z3VR Y | 1.00 | infobox |
The concept neighborhoods around Aplaviroc bring nearby vocabulary together. In this analysis, examples include Ccr5, Development and Discontinued. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
Bridges highlight paths between different parts of the Aplaviroc map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Aplaviroc to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Overview, Related Topics & Entities, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Aplaviroc · EN edition · Analysis: TopicsToTalkAbout